Physician profile
Dmitry Volkin
NPI 1508203316
$15,335.05
in general payments reported to CMS, 2019-2025
21 companies · $1,341 in 2025
The $1,341 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $11K · 2021: $1,296 · 2022: $400 · 2023: $357 · 2024: $234 · 2025: $1,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989 · Travel and Lodging: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.67 |
| Travel and Lodging | $943.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $10,164.25 | 2020 | |
| Medtronic, INC. | $3,060.56 | 2021-2025 | Interstim, Ligasure, Altaviva |
| Boston Scientific Corporation | $683.98 | 2020-2025 | Axonics |
| Coloplast Corp | $347.16 | 2019-2025 | |
| Astellas Pharma US INC | $240.90 | 2019 | |
| Amgen INC. | $174.22 | 2019 | |
| Axonics, INC. | $160.73 | 2021-2023 | Axonics |
| Janssen Biotech, INC. | $73.78 | 2019 | |
| Allergan, INC. | $71.32 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $57.53 | 2024 | Orgovyx |
| Abbvie INC. | $47.57 | 2023-2025 | Botox |
| Pfizer INC. | $43.89 | 2019 | |
| Bard Access Systems, INC. | $38.51 | 2019 | |
| Procept Biorobotics Corporation | $32.63 | 2024 | Aquabeam System |
| Rochester Medical Corporation | $29.82 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $26.76 | 2023 | Vapro Plus Pocket |
| Baxter Healthcare | $22.52 | 2024 | Tisseel |
| C. R. Bard, INC. & Subsidiaries | $17.66 | 2019 | |
| Endo Pharmaceuticals INC. | $15.84 | 2019 | |
| Telix Pharmaceuticals | $13.54 | 2023 | Illuccix |
| Ferring Pharmaceuticals INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitry Volkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.